Jump to content

benchmark

Member
  • Posts

    503
  • Joined

  • Last visited

Everything posted by benchmark

  1. If I understand you correctly. You are saying that exercise at $180, the buy some puts say Jan 24 $380 to hedge the potential drop of FB shares? I don't know much about 'portfolio' margin. The key difference seems to be that long options are marginable, but I don't know why this is required to execute the strategy?
  2. Can you expand on this? Are you saying that I if exercise at $180, then turn around and sell some long dated calls say $350 in Jan 24, IRS would somehow tax me? Are they taxing me because I exercised the option w/o paying taxes or are they taxing me on the long dated calls?
  3. Unfortunately, it will be greater than that The other choice I have is to sell some BAC to exercise FB, I think FB has a high growth potential than BAC -- w/o the dividend though
  4. I have some Jan 22 FB $180 option that are in the money. Selling it would mean sizable tax bill. I think FB has some additional growth to go -- my guess is that FB share would still grow at 10% going forward for the next 2-3 years, even with their meta adventure. However, exercising the option means that I'd have to use margin. Margin rate is manageable at the moment, but is this playing with fire? Are there other strategies that I'm not aware of?
  5. when you roll out the puts, don't you lose money on your current puts already?
  6. How did you short them after hours? what broker offers this?
  7. "junkiest of tech ETFs" What are some example of these type of ETFs?
  8. Rising yield might also push indicies higher https://www.forbes.com/sites/danrunkevicius/2021/03/04/rising-rates-are-great-for-the-stock-market-except-for-these-stocks/
  9. Keep them coming, I've learned something from your posts.
  10. Thanks. Looks like that the secondary offering in 2017 caused the stock to drop from $23 to ~$20?
  11. Thanks Wabuffo and Infeisone. This is helpful. Where was the last time that they did the secondary offer? Infeisone, I also own WMB, and am considering trimming as well fwiw
  12. is $20 your target price to unload? Given it's still paying 10%+ dividend, why not just keep it to continue to collect the divs...
  13. Fair enough, though I do want them to start with some solid understanding of investing -- maybe it's my bias, but I would not want them to buy TSLA or Gamestop just because everyone else is buying.
  14. 1) what's an easy to follow investment book that you'd recommend? 2) what are 1-3 stocks that one can do some analysis on? (i.e., not too complicated) Goal: 1) have them learn investing; 2) use the learning to analyze some stocks as practice and hopefully invest. thanks.
  15. What would you expect that bounce would be after the BK exit?
  16. Why selling it now? there should still be some room to run.
  17. Interesting, what's the best way to track/play 'gold'?
  18. it's still has a 8.23% yield at the current price. W/o doing anything, it's not a shabby return.
  19. Thank you Wabuffo. I have some questions regarding the timeline of this, especially with the long tail mentioned in the doc: • principal and interest payments due under a credit agreement entered into by the Company, as a lender, with CareView Communications, Inc., the recoverable amount of which is expected to be substantially less than the principal and interest payable; • amounts received in connection with our agreement with a counterparty pursuant to which we sold the remaining assets of DFM, LLC, to which we are entitled to a single-digit percentage of any net final award in connection with its monetization process using certain intangible assets included in the sale; • amounts received from a royalty based on a “know-how” license for technology provided in the design of solanezumab, an Eli Lilly-licensed humanized monoclonal antibody being tested in a study of older individuals who may be at risk of memory loss and cognitive decline due to Alzheimer’s disease. The 2% royalty on net sales is payable for 12.5 years after the product’s first commercial sale, and is currently in ongoing clinical studies with Phase 3 testing results expected in July of 2022; If they distribute the cash say by end of 2020, but receives royalty payment later. Is the shareholders supposed to track this themselves for tax purpose? How are these treated? Overall, what's your eval of the potential payment and timeline? thanks much.
×
×
  • Create New...